Innovation in myeloma treatments PARP excellence!

Rafael Fonseca

doi:10.1182/blood-2011-10-381129

Innovation in myeloma treatments PARP excellence!

Rafael Fonseca

Hematology/Oncology

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Abstract

In this issue of Blood, Neri and colleagues report a promising treatment of myeloma using a combination of bortezomib plus inhibition of the enzyme PARP1 (REF).¹This is welcome news, as new avenues for the treatment of the disease are needed.

Original language	English (US)
Pages (from-to)	6234-6235
Number of pages	2
Journal	Blood
Volume	118
Issue number	24
DOIs	https://doi.org/10.1182/blood-2011-10-381129
State	Published - Dec 8 2011

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2011-10-381129

Cite this

@article{ac4ab1f80a0c46bbbcc7606e38ecc4e6,

title = "Innovation in myeloma treatments PARP excellence!",

abstract = "In this issue of Blood, Neri and colleagues report a promising treatment of myeloma using a combination of bortezomib plus inhibition of the enzyme PARP1 (REF).1This is welcome news, as new avenues for the treatment of the disease are needed.",

author = "Rafael Fonseca",

year = "2011",

month = dec,

day = "8",

doi = "10.1182/blood-2011-10-381129",

language = "English (US)",

volume = "118",

pages = "6234--6235",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "24",

}

TY - JOUR

T1 - Innovation in myeloma treatments PARP excellence!

AU - Fonseca, Rafael

PY - 2011/12/8

Y1 - 2011/12/8

N2 - In this issue of Blood, Neri and colleagues report a promising treatment of myeloma using a combination of bortezomib plus inhibition of the enzyme PARP1 (REF).1This is welcome news, as new avenues for the treatment of the disease are needed.

AB - In this issue of Blood, Neri and colleagues report a promising treatment of myeloma using a combination of bortezomib plus inhibition of the enzyme PARP1 (REF).1This is welcome news, as new avenues for the treatment of the disease are needed.

UR - http://www.scopus.com/inward/record.url?scp=83455220284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83455220284&partnerID=8YFLogxK

U2 - 10.1182/blood-2011-10-381129

DO - 10.1182/blood-2011-10-381129

M3 - Comment/debate

C2 - 22161848

AN - SCOPUS:83455220284

SN - 0006-4971

VL - 118

SP - 6234

EP - 6235

JO - Blood

JF - Blood

IS - 24

ER -

Innovation in myeloma treatments PARP excellence!

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this